October’s pain management coverage examined postoperative suzetrigine, pharmacist follow-up for cancer-related neuropathic pain, constipation prevention, and counseling patients concerned about prescribed opioids.
|Articles|January 31, 2023
- January 2023
- Volume 89
- Issue 1
Pet Peeves- January 2023
Pharmacists want you to be on time.
Advertisement
Out of Time
Patients showing up more than 15 minutes late for an appointment and expecting us to accommodate them.
Articles in this issue
almost 4 years ago
Vivjoa From Mycovia Pharmaceuticals, Incalmost 4 years ago
Case Studies- January 2023almost 4 years ago
Consider 2 Safety Issues When Treating, Vaccinating for Monkeypoxalmost 4 years ago
January OTC Case Studies- Diabetesalmost 4 years ago
FDA Allows Access to Lifesaving Investigational Drugsalmost 4 years ago
Generic Product News for January 2023almost 4 years ago
PREP Act Provides Opportunities for Advanced Rolesalmost 4 years ago
What Is the Point of Point-of-Care Testing?almost 4 years ago
January 2023 Rx Product Newsalmost 4 years ago
Pharmacists Play Key Role in Encouraging COVID-19 Booster UptakeAdvertisement
Related to this article
CDC surveillance data show that approximately 10% of adults hospitalized with RSV died during hospitalization or within 60 days of discharge.
VAX-31 met all primary immunogenicity end points against PCV20 and PCV21 in the pivotal OPUS-1 trial.
Young adults who vaped daily but never smoked had lower flow-mediated dilation and peak oxygen uptake than peers who used neither product.
Expert Q&A: Geisinger Investigator Discusses Low Flu Vaccination Rates, ICU Findings in Older Adults
A study author explains how pharmacists can help close vaccination gaps in rural communities and what lower ICU admission rates among vaccinated older adults may mean.
From AKI dosing to CKM therapeutic inertia, experts at ASN Kidney Week 2026 pointed to pharmacists as key to moving new kidney data into practice.
Kidney Week 2026 posters show low-density lipoprotein cholesterol (LDL-C) fell by half in patients receiving dialysis, and oral enlicitide needed no dose adjustment for renal impairment.
Walgreens adds virtual coverage navigation, Medicare GLP-1 Bridge support, and pharmacist follow-up calls as GLP-1 discontinuation remains high.
Advertisement
Advertisement
Trending on Pharmacy Times
1
What Happens Before the First Dose? 5 Steps That Shape Lung Cancer Treatment
2
October 2026 in Pain Management: 4 Updates on Treatment and Pharmacy Practice
3
Nicotine Vaping Linked to Lower Vascular Function in Young Adults
4
Full IDWeek Data Highlights 31-Valent Pneumococcal Conjugate Vaccine Candidate in Adults
5